These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

566 related items for PubMed ID: 22155630

  • 41. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [Abstract] [Full Text] [Related]

  • 42. A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza.
    Kung HC, Huang KC, Kao TM, Lee YC, Chang FY, Wang NC, Liu YC, Lee WS, Liu HJ, Chen CI, Chen CH, Huang LM, Hsieh SM.
    Vaccine; 2010 Oct 21; 28(45):7337-43. PubMed ID: 20817013
    [Abstract] [Full Text] [Related]

  • 43. Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with type 1 diabetes mellitus.
    Zuccotti GV, Pariani E, Scaramuzza A, Santoro L, Giani E, Macedoni M, Gazzarri A, Anselmi G, Amendola A, Zanetti A.
    Diabet Med; 2011 Dec 21; 28(12):1530-6. PubMed ID: 21916971
    [Abstract] [Full Text] [Related]

  • 44. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
    Liu W, Ma MJ, Tang F, He C, Zhang XA, Jiang LF, Xin DS, Hu CY, Looman C, Cao WC.
    Vaccine; 2012 Jul 06; 30(32):4785-9. PubMed ID: 22633868
    [Abstract] [Full Text] [Related]

  • 45. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial.
    McKittrick N, Frank I, Jacobson JM, White CJ, Kim D, Kappes R, DiGiorgio C, Kenney T, Boyer J, Tebas P.
    Ann Intern Med; 2013 Jan 01; 158(1):19-26. PubMed ID: 23277897
    [Abstract] [Full Text] [Related]

  • 46. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.
    Roman F, Vaman T, Gerlach B, Markendorf A, Gillard P, Devaster JM.
    Vaccine; 2010 Feb 17; 28(7):1740-5. PubMed ID: 20034605
    [Abstract] [Full Text] [Related]

  • 47. Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial.
    Tsatsaris V, Capitant C, Schmitz T, Chazallon C, Bulifon S, Riethmuller D, Picone O, Poulain P, Lewin F, Lainé F, Jacqz-Aigrain E, Aboulker JP, Launay O, Inserm C09-33 PREFLUVAC (Immunogenicity and Safety of an Inactivated Nonadjuvanted A[H1N1v] Influenza Vaccine in Pregnant Women) Study Group.
    Ann Intern Med; 2011 Dec 06; 155(11):733-41. PubMed ID: 22147712
    [Abstract] [Full Text] [Related]

  • 48. Diminished immunogenicity to pandemic H1N1 2009 influenza vaccine in subjects with severe motor and intellectual disability.
    Hara M, Hanaoka T, Mizushima T, Honma J, Maeda K, Ohfuji S, Tanaka K, Hirota Y.
    Vaccine; 2011 Oct 26; 29(46):8323-9. PubMed ID: 21893146
    [Abstract] [Full Text] [Related]

  • 49. Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children.
    Scheifele DW, Ward BJ, Dionne M, Vanderkooi O, Langley JM, Dobson S, Li Y, Law B, Halperin SA, Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Rapid Trials Investigators.
    Pediatr Infect Dis J; 2011 May 26; 30(5):402-7. PubMed ID: 21178654
    [Abstract] [Full Text] [Related]

  • 50. Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients.
    Fabbiani M, Di Giambenedetto S, Sali M, Farina S, Sansonetti P, Tamburrini E, Dal Verme LZ, Delogu G, De Luca A, Kelvin D, Cauda R, Fadda G.
    Vaccine; 2011 Apr 05; 29(16):2836-9. PubMed ID: 21349364
    [Abstract] [Full Text] [Related]

  • 51. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
    Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM.
    N Engl J Med; 2009 Nov 12; 361(20):1945-52. PubMed ID: 19745214
    [Abstract] [Full Text] [Related]

  • 52. Immunogenicity and safety of influenza A (H1N1) 2009 monovalent inactivated split vaccine in Korea.
    Cheong HJ, Song JY, Heo JY, Noh JY, Choi WS, Park DW, Wie SH, Kim WJ.
    Vaccine; 2011 Jan 10; 29(3):523-7. PubMed ID: 21055502
    [Abstract] [Full Text] [Related]

  • 53. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
    Souza TM, Santini-Oliveira M, Martorelli A, Luz PM, Vasconcellos MT, Giacoia-Gripp CB, Morgado M, Nunes EP, Lemos AS, Ferreira AC, Moreira RI, Veloso VG, Siqueira M, Grinsztejn B, Camacho LA.
    J Med Virol; 2016 Mar 10; 88(3):426-36. PubMed ID: 26267817
    [Abstract] [Full Text] [Related]

  • 54. A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults.
    Talaat KR, Greenberg ME, Lai MH, Hartel GF, Wichems CH, Rockman S, Jeanfreau RJ, Ghosh MR, Kabongo ML, Gittleson C, Karron RA.
    J Infect Dis; 2010 Nov 01; 202(9):1327-37. PubMed ID: 20874515
    [Abstract] [Full Text] [Related]

  • 55. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.
    Plennevaux E, Sheldon E, Blatter M, Reeves-Hoché MK, Denis M.
    Lancet; 2010 Jan 02; 375(9708):41-8. PubMed ID: 20018365
    [Abstract] [Full Text] [Related]

  • 56. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.
    Nolan T, Richmond PC, Formica NT, Höschler K, Skeljo MV, Stoney T, McVernon J, Hartel G, Sawlwin DC, Bennet J, Ryan D, Basser RL, Zambon MC.
    Vaccine; 2008 Nov 25; 26(50):6383-91. PubMed ID: 18801398
    [Abstract] [Full Text] [Related]

  • 57. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
    Madhi SA, Dittmer S, Kuwanda L, Venter M, Cassim H, Lazarus E, Thomas T, Liberty A, Treurnich F, Cutland CL, Weinberg A, Violari A.
    AIDS; 2013 Jan 28; 27(3):369-79. PubMed ID: 23032417
    [Abstract] [Full Text] [Related]

  • 58. Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.
    Salles MJ, Sens YA, Malafronte P, Souza JF, Vilas Boas LS, Machado CM.
    Transpl Infect Dis; 2012 Dec 28; 14(6):564-74. PubMed ID: 22882692
    [Abstract] [Full Text] [Related]

  • 59. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults.
    Crum-Cianflone NF, Eberly LE, Duplessis C, Maguire J, Ganesan A, Faix D, Defang G, Bai Y, Iverson E, Lalani T, Whitman T, Blair PJ, Brandt C, Macalino G, Burgess T.
    Clin Infect Dis; 2011 Jan 01; 52(1):138-46. PubMed ID: 21148532
    [Abstract] [Full Text] [Related]

  • 60. Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus.
    Mathian A, Devilliers H, Krivine A, Costedoat-Chalumeau N, Haroche J, Huong DB, Wechsler B, Hervier B, Miyara M, Morel N, Le Corre N, Arnaud L, Piette JC, Musset L, Autran B, Rozenberg F, Amoura Z.
    Arthritis Rheum; 2011 Nov 01; 63(11):3502-11. PubMed ID: 21811996
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.